Betrecep 5mg Tablet
Prescription Required
Marketed By
pfizer
Pack of
14 Tablet
Salt Composition
Tofacitinib
Storage
Keep in cold place
₹400.74₹458.67
12.63% Off
Inclusive of all taxes
1
Betrecep 5mg Tablet
Delivering To: —
All Substitutes
Overview
Betrecep 5mg tablet is a prescription-based medicine used to treat people diagnosed with moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medicine helps to reduce the pain, tenderness, and swelling in the joints. This medicine also slows down the progression of bone and joint damage. It can be given alone or as part of a combination therapy for the best results.
Indication
Rheumatoid Arthritis, Ulcerative Colitis, Psoriatic Arthritis
Side Effects
The human body shows undesired symptoms after taking the Betrecep 5mg tablet. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of the Betrecep tablet are mentioned below:
Cough
Diarrhea
Skin rashes
Headache
Painful urination
Difficulty breathing
Inflammation of the nose
High cholesterol levels
Serious side effects are:
Skin blisters
Lung cancer
Blood cancer
Heart attack
Fever and chills
Blood in the stool
Stomach pain or abdominal pain
How To Use
The doctor determines the dosage and duration of treatment with Betrecep 5mg Tablet as per the patient's health condition. This medicine should be taken orally at the same time every day. Take it as a whole and don't crush or chew the medicine. This tablet can be taken with or without food. It is advised to take this medicine after consulting your healthcare expert.
How It Works
Betrecep 5mg tablet is a Janus kinase inhibitor as it contains Tofacitinib as an active ingredient. Janus kinase is a type of enzyme that comes under the category of tyrosine kinase. This enzyme is involved in the signaling of cytokine receptors. It's a medicine that blocks the action of Janus kinase, which automatically reduces the activity of the immune system. This results in decreased inflammation caused due to rheumatic diseases, ulcerative colitis, and other conditions treated by this medicine.
Safety Advice
Alcohol
consult your doctor
Avoid the consumption of alcohol while taking Betrecep 5mg Tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Do not take the Betrecep 5mg Tablet without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
consult your doctor
Betrecep 5mg Tablet is dangerous to use during breastfeeding as it may cause toxicity to the baby.
Driving
unsafe
Betrecep 5mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
safe if prescribed
Consumption of Betrecep 5mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.
Liver
safe if prescribed
Consumption of Betrecep 5mg Tablet should be avoided without informing the doctor if you have any liver-related issues.
Missed Doses
It is advised not to miss any scheduled dosage of the Betrecep 5mg tablet. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
It is advised to use effective birth control methods to avoid pregnancy. Some drugs can cause birth defects, miscarriage, or death to an unborn baby if the mother or father is using this medicine.
It is advised to tell your doctor about all medicines (multivitamins, herbal supplements) you're taking currently before starting your course with Betrecep medicines. There are chances that many drugs can interact, and some drugs should not be used together.
Inform your healthcare expert in case of severe blood infection, active tuberculosis, and liver problems.
FAQs
It is important to consult your doctor if you start observing swelling on your face, lips, tongue, throat, arms, or legs, and feel difficulty while swallowing or breathing. Betrecep tablet can reduce WBCs in your blood for a certain period and increase the chances of getting an infection.
Yes, this medicine can increase the level of cholesterol in the blood. It is advised to go for regular blood tests to check the count of different components of the blood.
Common side effects after taking Betrecep are Diarrhea, Skin rashes, Headache, Painful urination, Difficulty breathing, Inflammation of the nose, and High cholesterol levels. Consult your doctor if these side effects persist for a longer period and are causing severe health problems.
Betrecep 5mg tablet is used to treat patients diagnosed with Rheumatoid arthritis, Psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
This medicine works by blocking the action of Janus kinase, which automatically reduces the activity of the immune system. This results in decreased inflammation caused due to rheumatic diseases and ulcerative colitis.
Reference
1. Dowty, M. E., Lin, J., Ryder, T. F., Wang, W., Walker, G. S., Vaz, A., ... & Prakash, C. (2014). The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans. Drug Metabolism and Disposition, 42(4), 759-773.
2. Kremer, J., Li, Z. G., Hall, S., Fleischmann, R., Genovese, M., Martin-Mola, E., ... & Bradley, J. (2013). Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial. Annals of internal medicine, 159(4), 253-261.
3. Ruperto, N., Brunner, H. I., Synoverska, O., Ting, T. V., Mendoza, C. A., Spindler, A., ... & Weiss, J. E. (2021). Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. The Lancet, 398(10315), 1984-1996.
4. Cada, D. J., Demaris, K., Levien, T. L., & Baker, D. E. (2013). Tofacitinib. Hospital pharmacy, 48(5), 413-424.
5. Hodge, J. A., Kawabata, T. T., Krishnaswami, S., Clark, J. D., Telliez, J. B., Dowty, M. E., ... & Zwillich, S. (2016). The mechanism of action of tofacitinib-an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol, 34(2), 318-328.
6. Dhillon, S. (2017). Tofacitinib: a review in rheumatoid arthritis. Drugs, 77(18), 1987-2001.
Related Products
MARKETER DETAILS
pfizer
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.